Condensed Consolidated Statements of Operation (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Income Statement [Abstract]
Revenue
Cost of revenue			$ (12,000)	$ (6,000)
Gross profit			12,000	6,000
Operating expenses:
Research and development	$ 172,405	$ 138,806	504,415	673,173
General and administrative	284,724	280,000	1,010,989	1,092,689
Sales and marketing	50,700	114,178	184,660	344,529
Total operating expenses	507,829	532,984	1,700,064	2,110,391
Loss from operations	(507,829)	(532,984)	(1,688,064)	(2,104,391)
Other income (expense)
Interest expense	(183,184)	(131,846)	(474,727)	(347,587)
Change in fair value of derivative and warrant liabilities	753,538	1,883,289	353,315	(168,471)
Amortization of derivative and warrant liabilities discount	(176,661)	(396,853)	(699,957)	(850,691)
Amortization of deferred debt issuance costs and original issue discount	$ (90,130)	(85,034)	(262,520)	(197,608)
Gain on extinguishment of debt		227,259	119,369	227,259
Other income (expense), net	$ (4,893)	(5,343)	(9,527)	(20,523)
Total Other income (expense)	298,670	1,491,472	(974,047)	(1,357,621)
Net income (loss)	$ (209,159)	$ 958,488	$ (2,662,111)	$ (3,462,012)
Income (loss) per share:
Basic (in dollars per share)	$ (0.00)	$ 0.01	$ (0.01)	$ (0.02)
Fully diluted (in dollars per share)	$ (0.00)	$ 0.01	$ (0.01)	$ (0.02)
Weighted average common shares outstanding:
Basic (in shares)	198,039,192	171,996,818	196,519,704	169,070,461
Fully diluted (in shares)	198,039,192	186,965,778	196,519,704	169,070,461